CareDx (CDNA) Competitors

CareDx (NASDAQ:CDNA) and Privia Health Group (NASDAQ:PRVA) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, community ranking, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Does the MarketBeat Community favor CDNA or PRVA?

CareDx received 368 more outperform votes than Privia Health Group when rated by MarketBeat users. However, 76.00% of users gave Privia Health Group an outperform vote while only 65.78% of users gave CareDx an outperform vote.

Company	Underperform	Outperform
CareDx	Outperform Votes 444 65.78%	Underperform Votes 231 34.22%
Privia Health Group	Outperform Votes 76 76.00%	Underperform Votes 24 24.00%

Do analysts recommend CDNA or PRVA?

CareDx presently has a consensus target price of $30.33, indicating a potential upside of 70.99%. Privia Health Group has a consensus target price of $27.38, indicating a potential upside of 11.68%. Given CareDx's higher possible upside, equities research analysts clearly believe CareDx is more favorable than Privia Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareDx	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Privia Health Group	0 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.07

Do insiders and institutionals hold more shares of CDNA or PRVA?

94.5% of Privia Health Group shares are owned by institutional investors. 4.9% of CareDx shares are owned by insiders. Comparatively, 10.7% of Privia Health Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Which has more risk and volatility, CDNA or PRVA?

CareDx has a beta of 2.27, suggesting that its stock price is 127% more volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500.

Does the media prefer CDNA or PRVA?

In the previous week, CareDx had 1 more articles in the media than Privia Health Group. MarketBeat recorded 9 mentions for CareDx and 8 mentions for Privia Health Group. CareDx's average media sentiment score of 1.32 beat Privia Health Group's score of 0.82 indicating that CareDx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CareDx	8 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Privia Health Group	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better earnings and valuation, CDNA or PRVA?

Privia Health Group has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareDx	$346.42M	2.85	-$190.28M	$1.15	15.43
Privia Health Group	$1.80B	1.66	$23.08M	$0.12	204.33

Is CDNA or PRVA more profitable?

Privia Health Group has a net margin of 0.75% compared to CareDx's net margin of -45.90%. Privia Health Group's return on equity of 2.02% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareDx	-45.90%	-53.70%	-30.42%
Privia Health Group	0.75%	2.02%	1.21%

Summary

Privia Health Group beats CareDx on 12 of the 19 factors compared between the two stocks.